Skip to main navigation Skip to search Skip to main content

Development of Inhibitors of SAICAR Synthetase (PurC) from Mycobacterium abscessus Using a Fragment-Based Approach

  • Sitthivut Charoensutthivarakul
  • , Sherine E. Thomas
  • , Amy Curran
  • , Karen P. Brown
  • , Juan M. Belardinelli
  • , Andrew J. Whitehouse
  • , Marta Acebrón-García-de-Eulate
  • , Jaspar Sangan
  • , Subramanian G. Gramani
  • , Mary Jackson
  • , Vitor Mendes
  • , R. Andres Floto
  • , Tom L. Blundell
  • , Anthony G. Coyne
  • , Chris Abell
  • University of Cambridge
  • Mahidol University
  • Department of Medicine
  • Papworth Hospital
  • Colorado State University

Research output: Contribution to journal › Article › peer-review

13 Citations (Scopus)

Abstract

Mycobacterium abscessus (Mab) has emerged as a challenging threat to individuals with cystic fibrosis. Infections caused by this pathogen are often impossible to treat due to the intrinsic antibiotic resistance leading to lung malfunction and eventually death. Therefore, there is an urgent need to develop new drugs against novel targets in Mab to overcome drug resistance and subsequent treatment failure. In this study, SAICAR synthetase (PurC) from Mab was identified as a promising target for novel antibiotics. An in-house fragment library screen and a high-throughput X-ray crystallographic screen of diverse fragment libraries were explored to provide crucial starting points for fragment elaboration. A series of compounds developed from fragment growing and merging strategies, guided by crystallographic information and careful hit-to-lead optimization, have achieved potent nanomolar binding affinity against the enzyme. Some compounds also show a promising inhibitory effect against Mab and Mtb. This work utilizes a fragment-based design and demonstrates for the first time the potential to develop inhibitors against PurC from Mab.

Original languageEnglish
Pages (from-to)296-309
Number of pages14
JournalACS Infectious Diseases
Volume8
Issue number2
DOIs
Publication statusPublished - 11 Feb 2022
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Mycobacterium abscessus
  • PurC
  • SAICAR synthetase
  • cystic fibrosis
  • fragment-based drug discovery
  • structure-guided

Fingerprint

Dive into the research topics of 'Development of Inhibitors of SAICAR Synthetase (PurC) from Mycobacterium abscessus Using a Fragment-Based Approach'. Together they form a unique fingerprint.

Cite this